Matches in SemOpenAlex for { <https://semopenalex.org/work/W4321768340> ?p ?o ?g. }
- W4321768340 endingPage "621" @default.
- W4321768340 startingPage "616" @default.
- W4321768340 abstract "Background: Biosimilars are biological agents that have been demonstrated to have similar safety and efficacy profiles as the originator. The objective of this study was to evaluate the perspectives of pediatric gastroenterologists in the United States (U.S.) toward biosimilar use and to explore factors that impact their comfort level with prescribing infliximab biosimilars. Methods: A cross-sectional survey was developed and distributed to pediatric gastroenterology physicians from the U.S. via a listserv (Pediatric gastroenterology Bulletin Board). Respondent’s demographics were recorded. Using a 6-point Likert scale, the survey assessed the respondent’s perceptions toward biosimilars and initiating switches from the originator to biosimilar agent along with factors impacting provider’s comfort level. Fischer exact tests were used to detect statistically significant differences in responses for hypotheses of interest. Results: One hundred thirty-nine pediatric gastroenterologists completed the online survey (response rate 5.4%). Eighty-seven percent of respondents reported being comfortable prescribing infliximab biosimilars to anti-tumor necrosis factor naive patients, and 69% reported being comfortable doing a one-time switch if the patient was in clinical remission. Factors that negatively impacted a respondent’s comfort level included respondents not practicing at an ImproveCareNow (ICN) center and managing less than 50 patients with inflammatory bowel diseases (IBD). Conclusions: Nearly 90% of pediatric gastroenterologists felt comfortable prescribing an infliximab biosimilar, and 70% felt comfortable with a one-time switch to the biosimilar if the patient was in clinical remission. Involvement in ICN a learning health system and caring for higher numbers of patients with IBD was associated with increased provider comfort with biosimilar use." @default.
- W4321768340 created "2023-02-25" @default.
- W4321768340 creator A5004168081 @default.
- W4321768340 creator A5015076381 @default.
- W4321768340 creator A5021867379 @default.
- W4321768340 creator A5023198734 @default.
- W4321768340 creator A5042296236 @default.
- W4321768340 creator A5061619375 @default.
- W4321768340 creator A5066441208 @default.
- W4321768340 creator A5077971334 @default.
- W4321768340 date "2023-02-23" @default.
- W4321768340 modified "2023-10-18" @default.
- W4321768340 title "Biosimilars for Pediatric Patients With Inflammatory Bowel Disease: Pediatric Gastroenterology Clinical Practice Survey" @default.
- W4321768340 cites W1477056058 @default.
- W4321768340 cites W1996158630 @default.
- W4321768340 cites W2145436896 @default.
- W4321768340 cites W2272289608 @default.
- W4321768340 cites W2292830792 @default.
- W4321768340 cites W2578994901 @default.
- W4321768340 cites W2581233260 @default.
- W4321768340 cites W2791257230 @default.
- W4321768340 cites W2799534621 @default.
- W4321768340 cites W2885292041 @default.
- W4321768340 cites W2893638372 @default.
- W4321768340 cites W2910636195 @default.
- W4321768340 cites W2923675504 @default.
- W4321768340 cites W2963483045 @default.
- W4321768340 cites W2984387526 @default.
- W4321768340 cites W3008315775 @default.
- W4321768340 cites W3047235224 @default.
- W4321768340 cites W3093633730 @default.
- W4321768340 cites W3096200735 @default.
- W4321768340 cites W3122547945 @default.
- W4321768340 cites W3165670221 @default.
- W4321768340 cites W3172209242 @default.
- W4321768340 cites W4212976241 @default.
- W4321768340 cites W4285591833 @default.
- W4321768340 cites W3016144893 @default.
- W4321768340 doi "https://doi.org/10.1097/mpg.0000000000003750" @default.
- W4321768340 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36827968" @default.
- W4321768340 hasPublicationYear "2023" @default.
- W4321768340 type Work @default.
- W4321768340 citedByCount "3" @default.
- W4321768340 countsByYear W43217683402023 @default.
- W4321768340 crossrefType "journal-article" @default.
- W4321768340 hasAuthorship W4321768340A5004168081 @default.
- W4321768340 hasAuthorship W4321768340A5015076381 @default.
- W4321768340 hasAuthorship W4321768340A5021867379 @default.
- W4321768340 hasAuthorship W4321768340A5023198734 @default.
- W4321768340 hasAuthorship W4321768340A5042296236 @default.
- W4321768340 hasAuthorship W4321768340A5061619375 @default.
- W4321768340 hasAuthorship W4321768340A5066441208 @default.
- W4321768340 hasAuthorship W4321768340A5077971334 @default.
- W4321768340 hasConcept C126322002 @default.
- W4321768340 hasConcept C142052008 @default.
- W4321768340 hasConcept C142724271 @default.
- W4321768340 hasConcept C144024400 @default.
- W4321768340 hasConcept C149923435 @default.
- W4321768340 hasConcept C17744445 @default.
- W4321768340 hasConcept C199539241 @default.
- W4321768340 hasConcept C2776640315 @default.
- W4321768340 hasConcept C2777138892 @default.
- W4321768340 hasConcept C2778260677 @default.
- W4321768340 hasConcept C2779134260 @default.
- W4321768340 hasConcept C2780084366 @default.
- W4321768340 hasConcept C512399662 @default.
- W4321768340 hasConcept C59491497 @default.
- W4321768340 hasConcept C71924100 @default.
- W4321768340 hasConceptScore W4321768340C126322002 @default.
- W4321768340 hasConceptScore W4321768340C142052008 @default.
- W4321768340 hasConceptScore W4321768340C142724271 @default.
- W4321768340 hasConceptScore W4321768340C144024400 @default.
- W4321768340 hasConceptScore W4321768340C149923435 @default.
- W4321768340 hasConceptScore W4321768340C17744445 @default.
- W4321768340 hasConceptScore W4321768340C199539241 @default.
- W4321768340 hasConceptScore W4321768340C2776640315 @default.
- W4321768340 hasConceptScore W4321768340C2777138892 @default.
- W4321768340 hasConceptScore W4321768340C2778260677 @default.
- W4321768340 hasConceptScore W4321768340C2779134260 @default.
- W4321768340 hasConceptScore W4321768340C2780084366 @default.
- W4321768340 hasConceptScore W4321768340C512399662 @default.
- W4321768340 hasConceptScore W4321768340C59491497 @default.
- W4321768340 hasConceptScore W4321768340C71924100 @default.
- W4321768340 hasIssue "5" @default.
- W4321768340 hasLocation W43217683401 @default.
- W4321768340 hasLocation W43217683402 @default.
- W4321768340 hasOpenAccess W4321768340 @default.
- W4321768340 hasPrimaryLocation W43217683401 @default.
- W4321768340 hasRelatedWork W1981336058 @default.
- W4321768340 hasRelatedWork W2587157414 @default.
- W4321768340 hasRelatedWork W2774189845 @default.
- W4321768340 hasRelatedWork W2914211697 @default.
- W4321768340 hasRelatedWork W2914532353 @default.
- W4321768340 hasRelatedWork W2924476097 @default.
- W4321768340 hasRelatedWork W3010465489 @default.
- W4321768340 hasRelatedWork W4220693647 @default.
- W4321768340 hasRelatedWork W4229777120 @default.
- W4321768340 hasRelatedWork W4385064586 @default.